Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MDAI
Strong SellSinkerSpectral AI, Inc. · Healthcare · United States · $51M · Avg Vol: $250K/d
12
StockRankGet insider-trade alerts
Q
25
V
28
M
36
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
COMPANY DESCRIPTION
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 25.4M | 18.1M | 29.6M | 19.6M | -8.2% | 15.4M | 18.5M | 32.9M | 29.5% |
| EPS | — | -0.09 | -1.48 | -0.85 | -0.29 | — | -0.32 | -0.51 | -0.36 | — |
| Shares | — | 31.8M | 16.3M | 22.6M | 30.7M | -3.6% | 32.2M | — | — | — |
| Debt | — | 1.2M | 1.3M | 4.7M | 10.1M | 103.3% | 16.3M | — | — | — |
| Equity | — | 12.0M | -1.7M | -7.3M | -5.7M | — | — | — | — | — |
| Op CF | — | -1.2M | -13.2M | -9.2M | -9.9M | — | -12.9M | — | — | — |
| Inv CF | -7.0K | 0 | — | — | — | — | — | — | — | — |
| Fin CF | — | -0.8M | 3.8M | 9.6M | 20.1M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+5.3%
SMA 50SMA 200
Close
$1.58
RSI (14)
43.9
52W High
$2.97
From 52W High
0.5%
SCORE BREAKDOWN
Quality
25
ROIC
-803.5%0.6
ROE
—N/A
GP/Assets
30.9%65.3
Op. Margin
-122.7%15.8
FCF/Assets
-30.6%13.3
Piotroski
316.1
Int. Cover
-2.2x31.2
D/E Ratio
—N/A
Current Ratio
0.90x8.8
Value
28
P/E (TTM)
—N/A
EV/EBITDA
-4.5x25.0
P/FCF
—N/A
P/B
-4.2x25.0
P/S
3.3x54.0
Div Yield
—N/A
Momentum
36
52W High %
53%26.8
RS 6M
-0%65.3
SMA 50/200
0.97x48.6
EPS Rev 4W
0.0%34.5
EPS Rev 12W
—N/A
EPS Improve
-194%2.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$51M
P/E (Forward)
-1.7x
Gross Margin
42.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MDAI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MDAI | Spectral AI, Inc.(you) | $51M | 12 | Strong Sell |
| ELUT | Elutia Inc. | $51M | 13 | Strong Sell |
| COCH | Envoy Medical, Inc. | $53M | 10 | Strong Sell |
| ARAY | Accuray Incorporated | $53M | 19 | Strong Sell |
| HYPR | Hyperfine, Inc. | $88M | 12 | Strong Sell |
| SERA | Sera Prognostics, Inc. | $82M | 14 | Strong Sell |
| CVRX | CVRx, Inc. | $79M | 9 | Strong Sell |
| SRTS | Sensus Healthcare, Inc. | $58M | 22 | Sell |
| LDX.AX | Lumos Diagnostics Holdings Limited | $68M | 3 | Strong Sell |
| RPID | Rapid Micro Biosystems, Inc. | $79M | 6 | Strong Sell |
Peer medians: ROE -30.7% · P/E 27.0x · Gross margin 58.3%